Chimeric Antigen Receptor T-Cell Therapy in Dialysis-Dependent Patients With Multiple Myeloma: Insights From a 5-Case Series
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a transformative treatment for multiple hematologic malignancies, including multiple myeloma. However, patients with advanced chronic kidney disease, particularly those who are dialysis-dependent, have generally been excluded from clinica...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2025-12-01
|
| Collection: | Kidney Medicine |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2590059525001773 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|